Status:
NOT_YET_RECRUITING
Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
The goal of this randomized controlled clinical trial is to test the efficacy \& safety of stromal vascular fraction in treatment of AGA \& compare it to PRP The main questions it aims to answer are: ...
Detailed Description
* History taking from the patients is done about age, duration of the disease previous treatment, medical, surgical history \& family history. * Patients are subjected to clinical evaluation of severi...
Eligibility Criteria
Inclusion
- 18 years or older.
- Hamilton score I to VI in male patients.
Exclusion
- Patients with active infection, malignancy, autoimmune disease, and on current anticoagulant therapy.
- Patient on chemotherapy during the last 5 years.
- patients on topical or systemic treatment of AGA
Key Trial Info
Start Date :
August 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06558565
Start Date
August 30 2024
End Date
April 1 2025
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainy hospital
Cairo, Egypt